Placental protein 5 (PP5): biological and clinical studies.
D000022:Abortion, Spontaneous / Q000097:blood; D000037:Abruptio Placentae / Q000097:blood; D000990:Antithrombin III / Q000032:analysis; D001777:Blood Coagulation; D002824:Chorionic Villi / Q000032:analysis; D002850:Chromatography, Gel; D003920:Diabetes Mellitus / Q000097:blood; D005260:Female; D005317:Fetal Growth Retardation / Q000097:blood; D006023:Glycoproteins; D006801:Humans; D008970:Molecular Weight; D007752:Obstetric Labor, Premature / Q000097:blood; D011225:Pre-Eclampsia / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood; D011257:Pregnancy Proteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D011263:Pregnancy Trimester, Third; D011479:Protamines / Q000494:pharmacology; D014328:Trophoblastic Neoplasms / Q000097:blood; D014327:Trophoblasts / Q000032:analysis; D014427:Twins; D014594:Uterine Neoplasms / Q000097:blood
D006023:Glycoproteins; D011257:Pregnancy Proteins; D011479:Protamines; C021240:tissue-factor-pathway inhibitor 2; D000990:Antithrombin III